非酒精性脂肪性肝炎患者血清sCD163和IL-1βmRNA水平变化及其临床意义探讨

doi:10.3969/j.issn.1672-5069.2020.03.017

摘要/Abstract

摘要： 目的探讨非酒精性脂肪性肝炎(NASH)患者血清可溶性白细胞分化抗原163(sCD163)和白介素(IL)1βmRNA水平变化及其临床意义。方法 2016年1月～2018年3月我院消化内科就诊的NASH患者51例和健康人51例。采用ELISA法检测血清sCD163、内脂素和脂联素水平,采用RT-PCR法检测血清IL-1βmRNA水平。结果 NASH患者血糖(Glu)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)和总胆固醇(TC)水平为(6.1±1.4)mmol/L、(3.6±1.1)mmol/L、(2.9±0.4)mmol/L和(6.1±0.6)mmol/L,显著高于健康人【分别为(4.5±0.3)mmol/L、(2.5±0.9)mmol/L、(2.2±0.2)mmol/L和(4.5±0.3)mmol/L,P<0.05】;NASH患者血清sCD163、IL-1βmRNA、内脂素和脂联素水平分别为(70.7±10.4) ng/ml、(0.5±0.1)、(31.1±8.4)μg/ml和(6.8±1.3)μg/ml,与健康人【分别为(30.8±5.9) ng/ml、(0.1±0.2)、(15.9±2.6)μg/ml和(15.2±2.2)μg/ml,P<0.05】比,存在显著性差异; NASH患者血清ALT、AST和GGT水平分别为(73.5±3.9)U/L、(62.7±2.8)U/L和(108.0±4.1)U/L,显著高于健康人【分别为(33.5±3.9)U/L、(32.7±2.8)U/L和(48.0±4.1)U/L,P<0.05】。结论 NASH患者除了存在肝功能指标的异常和血糖血脂代谢紊乱外,还表现为血清血清sCD163、IL-1βmRNA和内脂素水平升高,脂联素水平降低。了解这些变化特征,可能对判断肝组织损伤程度和病情具有重要的临床意义。

关键词: 非酒精性脂肪性肝炎, 可溶性白细胞分化抗原163, 白介素1βmRNA, 内脂素, 脂联素 , ,

Abstract: Objective The aim of this study was to investigate the clinical implications of soluble cluster of differentiation 163 (sCD163) and interleukin (IL)1βmRNA in patients with nonalcoholic steatohepatitis (NASH). Methods 51 patients with NASH and 51 healthy persons were enrolled in the Department of Gastroenterology in our hospital between January 2016 and March 2018, and serum levels of sCD163, visfatin and adiponectin were detected by ELISA, and blood IL-1βmRNA was assayed by RT-PCR. Results Blood glucose, low density lipoprotein (LDL-C) , triglyceride (TG) and total cholesterol levels in patients with NASH were (6.1±1.4)mmol/L,(3.6±1.1)mmol/L,(2.9±0.4)mmol/L and (6.1±0.6)mmol/L, significantly higher than [(4.5±0.3)mmol/L,(2.5±0.9)mmol/L,(2.2±0.2)mmol/L and (4.5±0.3)mmol/L, respectively, P<0.05】 in the control; serum sCD163, IL-1βmRNA, visfatin and adiponectin levels in patients with NASH were (70.7±10.4) ng/ml, (0.5±0.1), (31.1±8.4)μg/ml and (6.8±1.3)μg/ml, significantly different compared to 【(30.8±5.9) ng/ml, (0.1±0.2), (15.9±2.6)μg/ml ad (15.2±2.2)μg/ml, respectively, P<0.05】 in healthy persons; serum alanine aminotransferase, aspartate aminotransferase and gamma glutamyltranspeptidase levels in patients with NASH were(73.5±3.9)U/L, (62.7±2.8)U/L and (108.0±4.1)U/L, significantly higher than 【(33.5±3.9)U/L, (32.7±2.8)U/L and (48.0±4.1)U/L, respectively, P<0.05】 in healthy persons. Conclusion The patients with NASH have abnormal liver function tests, blood glucose and lipid metabolism imbalance, besides, they have elevatedserum sCD163, IL-1βmRNA and visfatin levels, and decreased adiponectin levels, which might hint liver injuries and poor prognosis.

Key words: Non-alcoholic steatohepatitis, Soluble cluster of differentiation 163, Interleukin (IL) 1β mRNA, Visfatin, Adiponectin

方菊梅,张万里,陈怡发,刘黎明,黄庆勇. 非酒精性脂肪性肝炎患者血清sCD163和IL-1βmRNA水平变化及其临床意义探讨[J]. 实用肝脏病杂志, 2020, 23(3): 368-371.

Fang Jumei,Zhang Wanli,Chen Yifa ,et al.. Clinical implications of sCD163 and IL-1βmRNA in patients with nonalcoholic steatohepatitis[J]. Journal of Practical Hepatology, 2020, 23(3): 368-371.

参考文献

[1] Tang J T, Mao Y M. Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence.J Dig Dis, 2017, 18(11): 607-617.
[2] Kanwar P, Kowdley K V. The metabolic syndrome and its influence on nonalcoholic steatohepatitis. Clin Liver Dis, 2016, 20(2): 225-243.
[3] Jacobs A, Warda A S, Verbeek J, et al. An overview of mouse models of nonalcoholic steatohepatitis: from past to present. Curr Protoc Mouse Biol, 2016, 6(2): 185-200.
[4] Wang Y J, Gong Z Q, Bi X M, et al. Correlation of plasma soluble cluster of differentiation 40 ligand, alpha fetoprotein a, and pregnancy-associated plasma protein a with carotid plaque in patients with ischemic stroke. Genet Mol Res, 2015, 14(3): 8091-8099.
[5] Rios-Toro J J, Marquez-Coello M, Garcia-Alvarez J M, et al. Soluble membrane receptors, interleukin 6, procalcitonin and c reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS One, 2017, 12(4): e175254.
[6] 石翠翠,范建高. 美国非酒精性脂肪性肝病诊疗指南解读. 实用肝脏病杂志, 2017, 20(5): 646-648.
[7] 张兰华,邵琴,夏振娟. 非酒精性脂肪性肝病儿童血清25-(OH)D3和IL-17水平变化初步研究. 实用肝脏病杂志, 2019,22(4): 522-525.
[8] Zhi Y, Gao P, Xin X, et al. Clinical significance of scd163 and its possible role in asthma (review). Mol Med Rep, 2017, 15(5): 2931-2939.
[9] Bryant A K, Moore D J, Burdo T H, et al. Plasma soluble cd163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS, 2017, 31(7): 973-979.
[10] 信丰智,曹海霞,范建高. 胰高血糖素样肽-1改善非酒精性脂肪性肝病作用机制研究进展. 实用肝脏病杂志, 2018, 21(2): 313-316.
[11] 曾益林,倪永锐. 腹部超声对糖尿病合并非酒精性肝炎的筛查及相关因素. 世界华人消化杂志, 2016, 24(18): 2886-2891.
[12] Dekkema G J, Abdulahad W H, Bijma T, et al. Urinary and serum soluble cd25 complements urinary soluble cd163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study. Nephrol Dial Transplant, 2019, 34(2): 234-242.
[13] Kameoka S, Kameyama T, Hayashi T, et al. Helicobacter pylori induces IL-1beta protein through the inflammasome activation in differentiated macrophagic cells. Biomed Res, 2016, 37(1): 21-27.
[14] Pilkington SM, Ogden S, Eaton L H, et al. Lower levels of interleukin-1beta gene expression are associated with impaired langerhans' cell migration in aged human skin. Immunology, 2018, 153(1): 60-70.
[15] Kitade H, Chen G, Ni Y, et al. Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments. Nutrients,2017, 9(4): E387.
[16] Yki-Jarvinen H. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients, 2015, 7(11): 9127-9138.
[17] Chang ML, Hsu C M, Tseng JH, et al. Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders. J Gastroenterol Hepatol, 2015, 30(2): 329-336.
[18] Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, et al. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical Trials. Int J Mol Sci, 2016, 17(6):512-516.
[19] Farzanegi P, Dana A, Ebrahimpoor Z, et al. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (nafld): roles of oxidative stress and inflammation. Eur J Sport Sci,2019,19(7): 994-1003.
[20] Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: A secondary analysis of a randomized clinical trial. Ann Surg,2017,266(5): 738-745.
[21] Negroni A, Colantoni E, Vitali R, et al. Nod2 induces autophagy to control aiec bacteria infectiveness in intestinal epithelial cells. Inflamm Res, 2016, 65(10): 803-813.
[22] Fujimura T, Sato Y, Tanita K, et al. Serum level of soluble cd163 may be a predictive marker of the effectiveness of nivolumab in patients with advanced cutaneous melanoma. Front Oncol, 2018, 8: 530.